FEATURE ARTICLE
H–D Exchange Reaction
1477
[D]-N-(Chloroacetyl)-N,2-dimethyl-1-phenylpropan-2-amine
(19)
Oka, H. J. Chromatogr., B 1999, 732, 55. (m) Oba, Y.;
Kato, S.; Ojika, M.; Inouye, S. Tetrahedron Lett. 2002, 43,
2389. (n) Pavlik, J. W.; Laohhasurayotin, S. Tetrahedron
Lett. 2003, 44, 8109. (o) Babu, B. S.; Balasubramanian, K.
K. Carbohydr. Res. 2005, 340, 753. (p) Liu, H.-X.; Yao, Z.-
J. Tetrahedron Lett. 2005, 46, 3525. (q) Morrison, J. J.;
Botting, N. P. Tetrahedron Lett. 2007, 48, 1891.
To a soln of 17 (11.8 g, 44.9 mmol) in Et2O (118 mL) was added
dropwise concd HCl (27 g, 269 mmol) at r.t. and the mixture was
stirred for 3 h. To the resultant mixture was then added aq NaOH
until the pH reached 11. To the separated organic layer was added
2 M NaOH (71 mL, 141 mmol). Chloroacetyl chloride (7.7 g, 68.2
mmol) was added dropwise to the resultant mixture, and the mixture
was stirred at r.t. for 2 h. The separated organic layer was washed
with H2O (2 × 20 mL), brine (2 × 20 mL), and dried (MgSO4). Con-
centration of the soln in vacuo afforded the crude 19 (7.6 g, 69%
from 15), which was used in the next step without purification.
(3) (a) Koshino, A.; Tagawa, T. J. Appl. Polym. Chem. Sci.
1965, 9, 117. (b) Miller, M. S.; Klotz, I. M. J. Am. Chem.
Soc. 1973, 95, 5694. (c) Kaino, T.; Jinguji, K.; Nara, S.
Appl. Phys. Lett. 1982, 41, 802. (d) Kaino, T.; Jinguji, K.;
Nara, S. Appl. Phys. Lett. 1983, 42, 567.
(4) For example, D2 gas as a deuterium source: (a) Lebrilla, C.
B.; Maier, W. F. J. Am. Chem. Soc. 1986, 108, 1601.
(b) Heys, R. J. Chem. Soc., Chem. Commun. 1992, 680.
(c) Hesk, D.; Das, P. R.; Evans, B. J. Labelled Compd.
Radiopharm. 1995, 36, 497. (d) Chen, W.; Garnes, K. T.;
Levinson, S. H.; Saunders, D.; Senderoff, S. G.; Shu, A. Y.
L.; Villani, A. J.; Heys, J. R. J. Labelled Compd.
Isotope distribution (TOF-MS): 2% d6, 2% d7, 4% d8, 9% d9, 12%
d10, 19% d11, 29% d12, 23% d13.
1H NMR (CD2Cl2): d = 7.26 (s, 0.07 H), 7.21 (s, 0.03 H), 7.14 (s,
0.07 H), 4.06 (s, 2 H), 3.15 (d, 0.57 H), 2.56 (s, 3 H), 1.42–1.37 (m,
0.85 H).
2H NMR (CH2Cl2): d = 7.31–7.18 (br m), 3.16 (br s), 1.39 (br s).
Radiopharm. 1997, 39, 291. (e) Shu, A. Y. L.; Saunders, D.;
Levinson, S. H.; Landvatter, S. W.; Mahoney, A.; Senderoff,
S. G.; Mack, J. F.; Heys, J. R. J. Labelled Compd.
Radiopharm. 1999, 42, 797. (f) Hickey, M. J.; Jones, J. R.;
Kingston, L. P.; Lockley, W. J. S.; Mather, A. N.; McAuley,
B. M.; Wilkinson, D. J. Tetrahedron Lett. 2003, 44, 3959.
(g) Skaddan, M. B.; Yung, C. M.; Bergman, R. G. Org. Lett.
2004, 6, 11.
13C NMR (CD2Cl2): d = 166.8, 138.3, 130.4*, 127.6*, 125.9*, 60.4,
45.1, 43.2*, 33.7, 30.0*.
[D]-Oxethazaine (20-d)
A mixture of ethanolamine (0.85 g, 13.85 mmol), KI (0.46 g, 2.8
mmol), THF (52 mL), and 3 M NaOH (21.2 mL, 63.7 mmol) was
heated to 60 °C; then a soln of crude 19 (7.0 g, 27.7 mmol) in THF
(35 mL) was added dropwise to the mixture at the same tempera-
ture. The resultant mixture was refluxed for 6 h. After cooling, the
mixture was diluted with EtOAc (90 mL). The separated organic
layer was washed with H2O (2 × 35 mL) and brine (35 mL), dried
(MgSO4), and concentrated in vacuo. The residue was purified by
column chromatography (silica gel, CH2Cl2–MeOH, 20:1) to afford
20-d (6.6 g, 97%) as a pale yellow solid.
(5) For example benzene-d6 as a deuterium source: (a) Lenges,
C. P.; White, P. S.; Brookhart, M. J. Am. Chem. Soc. 1999,
121, 4385. (b) Golden, J. T.; Andersen, R. A.; Bergman, R.
G. J. Am. Chem. Soc. 2001, 123, 5837.
(6) (a) Garnett, J. L.; Hodges, R. J. J. Am. Chem. Soc. 1967, 89,
4546. (b) Garnett, J. L.; Hodges, R. J. Chem. Commun. 1967,
1001. (c) Bean, G. P.; Johnson, A. R.; Katritzky, A. R.;
Ridgewell, B. J.; White, A. M. J. Chem. Soc. B 1967, 1219.
(d) Long, M. A.; Garnett, J. L.; Vining, R. F. W.; Mole, T. J.
Am. Chem. Soc. 1972, 94, 8632. (e) Werstiuk, N. H.; Kadai,
T. Can. J. Chem. 1974, 52, 2169.
(7) (a) Tashiro, M.; Nakayama, K. J. Chem. Soc., Perkin Trans.
1 1983, 2315. (b) Iranzo, G. Y.; Elgureo, J. J. Labelled
Compd. Radiopharm. 1990, 28, 967. (c) Okazaki, M.;
Uchino, N.; Nozaki, N.; Kubo, K. Bull. Chem. Soc. Jpn.
1995, 68, 1024.
Isotope distribution (TOF-MS): 2% d17, 2% d18, 4% d19, 7% d20,
11% d21, 14% d22, 17% d23, 17% d24, 16% d25, 10% d26.
1H NMR (CD2Cl2): d = 7.24 (s, 0.18 H), 7.20 (s, 0.08 H), 7.12 (s,
0.20 H), 5.12 (br 1 H), 3.54 (m, 6 H), 3.16 (d, 0.1.36 H), 2.92 (t, 2
H), 2.49 (s, 6 H), 1.41–1.36 (m, 1.84 H).
2H NMR (CH2Cl2): d = 7.30 (br m), 3.19 (br s), 1.40 (br s).
13C NMR (CD2Cl2): d = 172.2, 138.8, 130.1*, 127.6*, 125.8*, 60.3,
59.9, 59.2, 58.4, 43.5*, 32.2, 27.0*.
(8) (a) Garnett, J. L.; Long, M. A.; McLaren, A. B.; Peterson, K.
B. J. Chem. Soc., Chem. Commun. 1973, 749. (b) Heys, J.
R.; Shu, A. Y. L.; Senderoff, S. G.; Phillips, N. M. J.
Labelled Compd. Radiopharm. 1993, 33, 431. (c) Lukey, C.
A.; Long, M. A.; Garnett, J. L. Aust. J. Chem. 1995, 48, 79.
(d) Klei, S. R.; Golden, J. T.; Tilley, T. D.; Bergman, R. G.
J. Am. Chem. Soc. 2002, 124, 2092.
(9) (a) Takahashi, M.; Oshima, K.; Matsubara, S. Chem. Lett.
2005, 34, 192. (b) Ishibashi, K.; Takahashi, M.; Yokota, Y.;
Oshima, K.; Matsubara, S. Chem. Lett. 2005, 34, 664.
(c) Ishibahsi, K.; Matsubara, S. Chem. Lett. 2007, 36, 724.
(d) Prechtl, M. H. G.; Holscher, M.; Ben-David, Y.;
Theyssen, N.; Loschen, R.; Milstein, D.; Leitner, W. Angew.
Chem. Int. Ed. 2007, 46, 2269.
(10) (a) Blake, M. R.; Garnett, J. L.; Gregor, I. K.; Hannan, W.;
Hoa, K.; Long, M. A. J. Chem. Soc., Chem. Commun. 1975,
930. (b) Hesk, D.; Jones, J. R.; Lockley, W. J. S. J. Labelled
Compd. Radiopharm. 1990, 28, 1427. (c) Hesk, D.; Jones, J.
R.; Lockley, W. J. S. J. Pharm. Sci. 1991, 80, 887.
(11) (a) Hardacre, C.; Holbrey, J. D.; McMath, S. E. J. Chem.
Commun. 2001, 367. (b) Matsubara, S.; Yokota, Y.;
Oshima, K. Chem. Lett. 2004, 33, 294. (c) Derdau, V.;
Atzrodt, J. Synlett 2006, 1918.
References
(1) For a review, see:Junk, T.; Catallo, W. J. Chem. Soc. Rev.
1997, 26, 401.
(2) (a) Tokuhisa, S.; Saisu, K.; Yoshikawa, H.; Tsuda, T.;
Morishita, T.; Baba, S. Chem. Pharm. Bull. 1978, 26, 3647.
(b) Campbell, R. E. Jr.; Lochow, C. F.; Vora, K. P.; Miller,
R. G. J. Am. Chem. Soc. 1980, 102, 5824. (c) Foster, A. B.
Trends Pharmacol. Sci. 1984, 5, 524. (d) Baldwin, J. E.;
Adlington, R. M.; Ting, H.-H.; Arigoni, D.; Graf, P.;
Martinoni, B. Tetrahedron 1985, 41, 3339. (e) Stevenson,
D. E.; Akhtar, M.; Gani, D. Tetrahedron Lett. 1986, 27,
5661. (f) Furuta, T.; Takahashi, H.; Kasuya, Y. J. Am. Chem.
Soc. 1990, 112, 3633. (g) Porter, D. J. T.; Boyd, F. L. J. Biol.
Chem. 1991, 266, 21616. (h) Murry, S.; Lynch, A. M. J.
Chromatogr. 1993, 616, 211. (i) Gardner, K. H.; Kay, L. E.
J. Am. Chem. Soc. 1997, 119, 7599. (j) Gygi, S. P.; Rist, B.;
Gerber, S. A.; Turecek, F.; Gelb, M. H.; Aebersold, R. Nat.
Biotechnol. 1998, 16, 939. (k) Liu, K.; Williams, J.; Lee, H.;
Fitzgerald, M. M.; Jensen, G. M.; Goodin, D. B.;
McDermott, A. E. J. Am. Chem. Soc. 1998, 120, 10199.
(l) Nakazawa, H.; Ino, S.; Kato, K.; Watanabe, T.; Ito, Y.;
Synthesis 2008, No. 9, 1467–1478 © Thieme Stuttgart · New York